Medical Properties (MPT) Skyrockets on 88% Narrower Loss

We recently published 10 Firms Outperform Wall Street With Surprising Gains. Medical Properties Trust Inc. (NYSE:MPT) was one of the best performers on Thursday.

Medical Properties snapped a four-day losing streak on Thursday, soaring 12.10 percent to finish at $6.02 apiece after narrowing its losses by 88 percent last year.

In an updated report, Medical Properties Trust Inc. (NYSE:MPT) said net loss attributable to shareholders shrank to $277 million from $2.4 billion in 2024, despite total revenues dipping by 2.3 percent to $972 million from $995 million.

In the fourth quarter alone, the company swung to a net income attributable to shareholders of $17.3 million from a $412.8 million attributable net loss in the same quarter a year earlier.

Medical Properties (MPT) Skyrockets on 88% Narrower Loss

Total revenues grew by 16.6 percent to $270.3 million from $231.8 million year-on-year.

Following the results, Medical Properties Trust Inc. (NYSE:MPT) Chairman, President, and CEO Edward Aldag said that the company’s current portfolio continues to bring more rental income, and that it can now focus on strengthening its balance sheet after Prospect Medical officially resolved its Chapter 11 bankruptcy filed in 2025, leaving the listed firm with receivables from unpaid rents.

In other news, Medical Properties Trust Inc. (NYSE:MPT) declared a cash dividend of $0.09 to all common stockholders on record as of March 12, payable on April 9, 2026.

While we acknowledge the risk and potential of MPT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MPT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.